Literature DB >> 22678998

Postprandial inhibition of gastric ghrelin secretion by long-chain fatty acid through GPR120 in isolated gastric ghrelin cells and mice.

Xinping Lu1, Xilin Zhao, Jianying Feng, Alice P Liou, Shari Anthony, Susanne Pechhold, Yuxiang Sun, Huiyan Lu, Stephen Wank.   

Abstract

Ghrelin is a gastric peptide hormone that controls appetite and energy homeostasis. Plasma ghrelin levels rise before a meal and fall quickly thereafter. Elucidation of the regulation of ghrelin secretion has been hampered by the difficulty of directly interrogating ghrelin cells diffusely scattered within the complex gastric mucosa. Therefore, we generated transgenic mice with ghrelin cell expression of green fluorescent protein (GFP) to enable characterization of ghrelin secretion in a pure population of isolated gastric ghrelin-expressing GFP (Ghr-GFP) cells. Using quantitative RT-PCR and immunofluorescence staining, we detected a high level of expression of the long-chain fatty acid (LCFA) receptor GPR120, while the other LCFA receptor, GPR40, was undetectable. In short-term-cultured pure Ghr-GFP cells, the LCFAs docosadienoic acid, linolenic acid, and palmitoleic acid significantly suppressed ghrelin secretion. The physiological mechanism of LCFA inhibition on ghrelin secretion was studied in mice. Serum ghrelin levels were transiently suppressed after gastric gavage of LCFA-rich lipid in mice with pylorus ligation, indicating that the ghrelin cell may directly sense increased gastric LCFA derived from ingested intraluminal lipids. Meal-induced increase in gastric mucosal LCFA was assessed by measuring the transcripts of markers for tissue uptake of LCFA, lipoprotein lipase (LPL), fatty acid translocase (CD36), glycosylphosphatidylinositol-anchored HDL-binding protein 1, and nuclear fatty acid receptor peroxisome proliferator-activated receptor-γ. Quantitative RT-PCR studies indicate significantly increased mRNA levels of lipoprotein lipase, glycosylphosphatidylinositol-anchored HDL-binding protein 1, and peroxisome proliferator-activated receptor-γ in postprandial gastric mucosa. These results suggest that meal-related increases in gastric mucosal LCFA interact with GPR120 on ghrelin cells to inhibit ghrelin secretion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22678998      PMCID: PMC3774249          DOI: 10.1152/ajpgi.00541.2011

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  46 in total

1.  Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations.

Authors:  Heung-Man Lee; Guiyun Wang; Ella W Englander; Masayasu Kojima; George H Greeley
Journal:  Endocrinology       Date:  2002-01       Impact factor: 4.736

2.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.

Authors:  D E Cummings; J Q Purnell; R S Frayo; K Schmidova; B E Wisse; D S Weigle
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

3.  Ghrelin enhances appetite and increases food intake in humans.

Authors:  A M Wren; L J Seal; M A Cohen; A E Brynes; G S Frost; K G Murphy; W S Dhillo; M A Ghatei; S R Bloom
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

4.  Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans.

Authors:  Y Date; M Kojima; H Hosoda; A Sawaguchi; M S Mondal; T Suganuma; S Matsukura; K Kangawa; M Nakazato
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

5.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

6.  Somatostatin suppresses ghrelin secretion from the rat stomach.

Authors:  Mitsushi Shimada; Yukari Date; Muhtashan S Mondal; Koji Toshinai; Takuya Shimbara; Kyoko Fukunaga; Noboru Murakami; Mikiya Miyazato; Kenji Kangawa; Hironobu Yoshimatsu; Hisayuki Matsuo; Masamitsu Nakazato
Journal:  Biochem Biophys Res Commun       Date:  2003-03-14       Impact factor: 3.575

7.  Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake.

Authors:  Bas Teusink; Peter J Voshol; Vivian E H Dahlmans; Patrick C N Rensen; Hanno Pijl; Johannes A Romijn; Louis M Havekes
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

Review 8.  GPIHBP1, a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins.

Authors:  Anne P Beigneux; Brandon S J Davies; André Bensadoun; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2008-10-14       Impact factor: 5.922

Review 9.  Fate of fatty acids at rest and during exercise: regulatory mechanisms.

Authors:  M D Jensen
Journal:  Acta Physiol Scand       Date:  2003-08

10.  Meal-related ghrelin suppression requires postgastric feedback.

Authors:  Diana L Williams; David E Cummings; Harvey J Grill; Joel M Kaplan
Journal:  Endocrinology       Date:  2003-07       Impact factor: 4.736

View more
  39 in total

1.  A Strong Stomach for Somatostatin.

Authors:  Bharath K Mani; Jeffrey M Zigman
Journal:  Endocrinology       Date:  2015-11       Impact factor: 4.736

2.  Mercaptoacetate and fatty acids exert direct and antagonistic effects on nodose neurons via GPR40 fatty acid receptors.

Authors:  Rebecca A Darling; Huan Zhao; Dallas Kinch; Ai-Jun Li; Steven M Simasko; Sue Ritter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-04-23       Impact factor: 3.619

3.  Ghrelin induces gastric cancer cell proliferation, migration, and invasion through GHS-R/NF-κB signaling pathway.

Authors:  Chuang Tian; Lianhai Zhang; Daohu Hu; Jiafu Ji
Journal:  Mol Cell Biochem       Date:  2013-06-27       Impact factor: 3.396

4.  Changes in small intestinal motility and related hormones by acupuncture stimulation at Zusanli (ST 36) in mice.

Authors:  Jung-Hee Jang; Deuk-Joo Lee; Chang-Hwan Bae; Ki-Tae Ha; Sunoh Kwon; Hi-Joon Park; Dae-Hyun Hahm; Hyejung Lee; Seungtae Kim
Journal:  Chin J Integr Med       Date:  2016-09-01       Impact factor: 1.978

5.  Mechanisms of homologous and heterologous phosphorylation of FFA receptor 4 (GPR120): GRK6 and PKC mediate phosphorylation of Thr³⁴⁷, Ser³⁵⁰, and Ser³⁵⁷ in the C-terminal tail.

Authors:  Rebecca N Burns; Monalisa Singh; Ilya S Senatorov; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2014-01-08       Impact factor: 5.858

Review 6.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

7.  Hypoglycemic Effect of Combined Ghrelin and Glucagon Receptor Blockade.

Authors:  Bharath K Mani; Aki Uchida; Young Lee; Sherri Osborne-Lawrence; Maureen J Charron; Roger H Unger; Eric D Berglund; Jeffrey M Zigman
Journal:  Diabetes       Date:  2017-05-09       Impact factor: 9.461

8.  Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells.

Authors:  Maja S Engelstoft; Won-Mee Park; Ichiro Sakata; Line V Kristensen; Anna Sofie Husted; Sherri Osborne-Lawrence; Paul K Piper; Angela K Walker; Maria H Pedersen; Mark K Nøhr; Jie Pan; Christopher J Sinz; Paul E Carrington; Taro E Akiyama; Robert M Jones; Cong Tang; Kashan Ahmed; Stefan Offermanns; Kristoffer L Egerod; Jeffrey M Zigman; Thue W Schwartz
Journal:  Mol Metab       Date:  2013-09-04       Impact factor: 7.422

9.  Post-oral fat stimulation of intake and conditioned flavor preference in C57BL/6J mice: A concentration-response study.

Authors:  Karen Ackroff; Anthony Sclafani
Journal:  Physiol Behav       Date:  2014-02-28

10.  Fasting-induced increase in plasma ghrelin is blunted by intravenous alcohol administration: a within-subject placebo-controlled study.

Authors:  Lorenzo Leggio; Melanie L Schwandt; Emily N Oot; Alexandra A Dias; Vijay A Ramchandani
Journal:  Psychoneuroendocrinology       Date:  2013-09-13       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.